Concepedia

Atin Lamsal

AL

Statistics

Publications

15

Citations

679

H-Index

14

Active since

2012

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

AstraZeneca (United States)

John F. Kennedy Center for the Performing Arts

Scripps Research Institute

Atin Lamsal is an author at Vanderbilt University specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2012–2017

15

Publications

15

Selective Activation of M<sub>4</sub>Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents

Michael Bubser, Thomas M. Bridges, Ditte Dencker et al. · ACS Chemical Neuroscience · 2014 · 155 citations · Full text

, , +17

Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model

Ayan Ghoshal, Jerri M. Rook, Jonathan W. Dickerson et al. · Neuropsychopharmacology · 2015 · 107 citations · Full text

, , +14

Discovery of VU0467485/AZ13713945: An M<sub>4</sub> PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia

Michael R. Wood, Meredith J. Noetzel, Bruce J. Melancon et al. · ACS Medicinal Chemistry Letters · 2016 · 54 citations · Full text

, , +17

Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptor

James M. Salovich, Paige N. Vinson, Douglas J. Sheffler et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 44 citations · Full text

, , +13

Challenges in the development of an M4 PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogs

Michael R. Wood, Meredith J. Noetzel, Michael S. Poslusney et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 42 citations · Full text

, , +9

1–5 of 15